Prime’s expertise and insight on managing pharmacy benefits is driven by its strong clinical foundation and unique connection with health plans. Our ability to analyze combined medical and pharmacy data results in a deeper understanding of the association between pharmacy care and overall health. Prime applies this insight to deliver the best health outcomes for members.
In April, researchers from Prime will present ten new research posters at the annual Academy of Managed Care Pharmacy spring conference. Use these links to download the posters:
- Total cost of care: Association between generic statin adherence and hospitalizations/total cost of care
- Integrated Medical/Pharmacy: Integrated analysis of Hepatitis C costs and use
- Mail service pharmacy: Immunosuppressant therapy waste associated with 30- and 90-day supplies
- Utilization management: Clinical and cost impact of a prior authorization for powerful antibiotic Zyvox®
- Formulary: Dose escalation in the high-cost autoimmune category
- Integrated Medical/Pharmacy: Integrated analysis of Tysabri® use and costs
- Specialty: Time to discontinuation for newly-initiated biologic therapy for Adult Crohn’s Disease and Rheumatoid Arthritis
- Specialty: Prevalence and rate of new biologic anti-inflammatory agent use
- Specialty: Prediction that by 2018, more than 50 percent of all drug expenditures will be specialty
- Integrated Medical/Pharmacy: Integrated cost analysis of Rheumatoid Arthritis drug users
Industry hot topics
Learn from our experts
Drug discount cards and coupons are marketing tools that have proven effective in changing consumers’ medical product preferences and purchasing habits. While coupons often help make expensive specialty drugs more affordable for members, Prime believes some coupons are deceptive to consumers and may ultimately lead to higher overall health care costs. These coupons are specifically designed to encourage negative behaviors, such as using a brand name drug when a less expensive generic version exists.
As more and more brand name drugs lose patent protection, coupons have become a popular way for drug manufacturers to retain or grow their market share. In recent years drug manufacturers have offered significantly more discount coupons and programs, and more consumers are using them. Our new position paper explains the difference between “good” and “bad” coupons and suggests strategies plan sponsors can use to limit undesirable coupon use. Click here to read Prime's position paper.